Header Logo

Connection

MAKSIM MAMONKIN to Neoplasms

Back to Details
This is a "connection" page, showing publications MAKSIM MAMONKIN has written about Neoplasms.
MAKSIM MAMONKIN
Connection Strength
0.391
Neoplasms
  1. CRISPR-Edited Immune Effectors: The End of the Beginning. Mol Ther. 2020 04 08; 28(4):995-996.
    View in: PubMed
    Score: 0.245
  2. Apoptosis of Hematopoietic Stem Cells Contributes to Bone Marrow Suppression Following Chimeric Antigen Receptor T Cell Therapy. Transplant Cell Ther. 2023 03; 29(3):165.e1-165.e7.
    View in: PubMed
    Score: 0.074
  3. Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs. Blood. 2022 07 07; 140(1):16-24.
    View in: PubMed
    Score: 0.072
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.